Engineered Small Pox May Kill Liver Cancer, University of California, San Diego (UCSD) Study

Published: Apr 10, 2013

As part of a multicenter clinical trial, researchers at University of California, San Diego School of Medicine are evaluating Pexa-Vec (JX-594) to slow the progression of hepatocellular carcinoma (HCC) or liver cancer. Pexa-Vec is a genetically engineered virus that is used in the smallpox vaccine.

Back to news